The expression and function of PD-L1/PD-1 pathway in the human cancer microenvironment (27, 28) was closely associated with tumor immune response, and the PD-L1 protein expression in tumor cells may predict responses to immune checkpoint inhibitors (29, 30). The gene discussed is PDCD1; the disease is neoplasm.